Acumen Wealth Advisors LLC Sells 8,327 Shares of Cigna Group $CI

Acumen Wealth Advisors LLC lowered its holdings in Cigna Group (NYSE:CI) by 89.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 939 shares of the health services provider’s stock after selling 8,327 shares during the quarter. Acumen Wealth Advisors LLC’s holdings in Cigna Group were worth $259,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Assetmark Inc. grew its position in Cigna Group by 10.0% in the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after acquiring an additional 5,963 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in Cigna Group by 41.1% in the fourth quarter. Victory Capital Management Inc. now owns 1,348,713 shares of the health services provider’s stock valued at $371,206,000 after acquiring an additional 392,978 shares in the last quarter. WASHINGTON TRUST Co increased its position in Cigna Group by 297.0% during the 4th quarter. WASHINGTON TRUST Co now owns 5,296 shares of the health services provider’s stock valued at $1,458,000 after purchasing an additional 3,962 shares during the period. Handelsbanken Fonder AB raised its holdings in Cigna Group by 12.1% in the 2nd quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock worth $22,833,000 after purchasing an additional 8,960 shares in the last quarter. Finally, CWM LLC lifted its position in Cigna Group by 12.7% during the fourth quarter. CWM LLC now owns 84,803 shares of the health services provider’s stock valued at $23,340,000 after buying an additional 9,566 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CI shares. Royal Bank Of Canada raised their price target on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. Mizuho increased their price target on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Robert W. Baird set a $362.00 price target on shares of Cigna Group in a research report on Friday, July 31st. The Goldman Sachs Group boosted their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Insider Buying and Selling

In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Trading Up 1.5%

NYSE:CI opened at $282.24 on Friday. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The firm has a market capitalization of $74.58 billion, a price-to-earnings ratio of 11.68, a price-to-earnings-growth ratio of 0.96 and a beta of 0.29. The business has a fifty day moving average price of $286.02 and a 200-day moving average price of $281.28. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the firm earned $7.20 earnings per share. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is currently 25.82%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.